pre-seed
Stage
1
Investors
About
Biomia develops novel small molecule therapeutics for central nervous system disorders using AI-driven discovery combined with yeast-based precision fermentation and synthetic biology.
Explore Biomia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.